RecallDepth
Class II Ongoing

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15

This recall is currently active, issued April 17, 2024. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
March 28, 2024
Posted
April 17, 2024
Recall Number
D-0439-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,304 3x10-cartons
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 100044259, Exp 06/30/2025.

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls